Table 1 Screening guidelines of 2020 American Cancer Society (ACS)10 vs United States Preventive Services Taskforce (USPSTF) endorsed by American Society for Coloscopy and Cervical Pathology (ASCCP)11.
Age | 2020 ACS |
|---|---|
Aged < 25 year | No screening |
Aged 25–65 year | Primary HPV test alone every 5 year (preferred) or, in case HPV testing is limited or not available, other options are like (Co-testing every 5 years OR Cytology alone evey 3 years) are acceptable |
Aged > 65 year | Discontinue screening if adequate negative prior screening |
Without documentation of prior screening, it should continue screening until criteria for cessation are met | |
After hysterectomy | Individuals without a cervix and without a history of CIN2 or a more severe diagnosis in the past 25 year or cervical cancer ever should not be screened |
Age | 2019 ASCCP |
|---|---|
Aged < 21 year | No screening |
Aged 21–29 year | Cytology alone every 3 years |
Aged 30–65 year | Either one of these methods: (1) Cytology every 3 years (2) hrHPV testing every 5 years (3) Co-testing (hrHPV testing + Cytology) every 5 years |
After 65 years | No screening after adequate negative previous results |
After hysterectomy | Individuals without a cervix and without a history of CIN2 or a more severe diagnosis in the past 25 year or cervical cancer ever should not be screened |
